Viewing Study NCT00109161

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 1:03 PM

Ignite Modification Date: 2026-01-08 @ 3:42 PM

Study NCT ID: NCT00109161

Status: COMPLETED

Last Update Posted: 2008-08-05

First Post: 2005-04-22

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis

Sponsor: PDL BioPharma, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module